Research Achievements
Newly Initiated Clinical Trials
Number of newly initiated Phase 1 · Phase 2 · Phase 3 clinical trials (2016 – 2025)
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
- Phase 1
- Phase 2
- Phase 3
| Year | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|
| 2016 | 65 | 73 | 103 |
| 2017 | 58 | 55 | 130 |
| 2018 | 79 | 71 | 100 |
| 2019 | 78 | 78 | 134 |
| 2020 | 96 | 90 | 116 |
| 2021 | 105 | 108 | 154 |
| 2022 | 94 | 87 | 107 |
| 2023 | 94 | 64 | 147 |
| 2024 | 103 | 78 | 151 |
| 2025 | 85 | 86 | 150 |
Phase 1 Trial Statistics
Number of Phase 1 clinical trials by department – Hematology-Oncology, Clinical Pharmacology, Others (cumulative); including FIH · Global FIH
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
- Hematology-Oncology
- Clinical Pharmacology
- Others
- FIH
- Global FIH
- Total
| Year | Hematology-Oncology | Clinical Pharmacology | Others | FIH | Global FIH | Total |
|---|---|---|---|---|---|---|
| 2016 | 35 | 17 | 13 | 22 | 17 | 65 |
| 2017 | 34 | 16 | 8 | 10 | 3 | 58 |
| 2018 | 42 | 25 | 12 | 10 | 6 | 79 |
| 2019 | 33 | 25 | 20 | 15 | 12 | 78 |
| 2020 | 51 | 23 | 22 | 25 | 20 | 96 |
| 2021 | 64 | 25 | 16 | 32 | 25 | 105 |
| 2022 | 54 | 24 | 16 | 34 | 19 | 94 |
| 2023 | 61 | 19 | 14 | 44 | 32 | 94 |
| 2024 | 69 | 21 | 13 | 46 | 25 | 103 |
| 2025 | 71 | 8 | 6 | 29 | 36 | 85 |
Hematology-Oncology Trial Statistics
Hematology-Oncology detail – number of Phase 1 · Phase 2 · Phase 3 trials (2016 – 2025)
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
- Phase 1
- Phase 2
- Phase 3
| Year | Phase 1 | Phase 2 | Phase 3 | Total |
|---|---|---|---|---|
| 2016 | 35 | 42 | 25 | 102 |
| 2017 | 34 | 31 | 47 | 112 |
| 2018 | 42 | 43 | 32 | 117 |
| 2019 | 33 | 45 | 47 | 125 |
| 2020 | 51 | 44 | 44 | 139 |
| 2021 | 64 | 52 | 61 | 177 |
| 2022 | 54 | 45 | 33 | 132 |
| 2023 | 61 | 28 | 35 | 124 |
| 2024 | 66 | 37 | 60 | 163 |
| 2025 | 64 | 33 | 53 | 150 |